Synthesis of dolastatin 15 mimetic peptoids

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 4, 1998, Pages 385-388

  Schmitt, Jörg ^a   Bernd, Michael ^b   Kutscher, Bernhard ^b   Kessler, Horst ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT; DOLASTATIN; DOLASTATIN 10;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SYNTHESIS; MOLLUSC; NONHUMAN; PEPTIDE SYNTHESIS;

ANTINEOPLASTIC AGENTS; DEPSIPEPTIDES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDES; PEPTOIDS; TUMOR CELLS, CULTURED;

EID: 0032539636     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00034-1     Document Type: Article

References (17)

1. 1. König, G. M.; Wright, A. D. Planta Medica 1996, 62, 193-211; Flam, F. Science 1994, 266, 1324-1325.
2. 1. König, G. M.; Wright, A. D. Planta Medica 1996, 62, 193-211; Flam, F. Science 1994, 266, 1324-1325.
3. 2. Pettit, G. R.; Singh, S. B.; Hogan, F.; Burkett, D. D. J. Med Chem. 1990, 33, 3133-3138.
4. 3. Pettit, G. R.; Kamano, Y.; Herald, C. L.; Fujii, Y.; Kizu, H.; Boyd, M. R. Boettner, F. E.; Doubek, D. L.; Schmidt, J. M.; Chapuis, J.-C.; Michel, C. Tetrahedron 1993, 49, 9151-9170.
5. 4. Hauthal, H. G. Nachr. Chem. Tech. Lab. 1995, 43, 1206-1208.
6. 5. Bai, R.; Pettit, G. R.; Hamel, E. J. Biol. Chem. 1990, 265, 17141-17149; Bai, R.; Friedman, S. J.; G. R. Pettit, Hamel, E. Biochem. Pharmacol. 1992, 43, 2637-2645.
7. 5. Bai, R.; Pettit, G. R.; Hamel, E. J. Biol. Chem. 1990, 265, 17141-17149; Bai, R.; Friedman, S. J.; G. R. Pettit, Hamel, E. Biochem. Pharmacol. 1992, 43, 2637-2645.
8. 6. de Arruda, M.; Cocchiaro, C. A.; Nelson, C. M.; Grinnell, C. M.; Janssen, B.; Haupt, A.; Barlozzari, T. Cancer Res. 1995, 55, 3085-3092.
9. 7. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., Marlowe, C. K., Spellmeyer, D. C., Tan R., Frankel, A. D., Santi, D. V., Cohen, F. E., Bartlett, P. A. Proc. Natl. Acad. Sci. 1992 89, 9367-9371; Kessler, H., Angew. Chem. 1993, 105, 572-573; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.
10. 7. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., Marlowe, C. K., Spellmeyer, D. C., Tan R., Frankel, A. D., Santi, D. V., Cohen, F. E., Bartlett, P. A. Proc. Natl. Acad. Sci. 1992 89, 9367-9371; Kessler, H., Angew. Chem. 1993, 105, 572-573; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.
11. 7. Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., Marlowe, C. K., Spellmeyer, D. C., Tan R., Frankel, A. D., Santi, D. V., Cohen, F. E., Bartlett, P. A. Proc. Natl. Acad. Sci. 1992 89, 9367-9371; Kessler, H., Angew. Chem. 1993, 105, 572-573; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.
12. 8. Chorev, M.; Goodman, M. TIBTECH 1995, 13, 438-445 and references cited therein.
13. 9. Miyazaki, K.; Kobayashi, M.; Natsume, T.; Gondo, M.; Mikami, T.; Sakakibara, K.; Tsukagoshi, S. Chem. Pharm. Bull 1995, 43, 1706-1718;
14. Pettit, G. R.; Srirangam, J. K.; Barkoczy, J.; Williams, M. D.; Durkin, K. P. M.; Boyd, M. R.; Bai, R.; Hamel, E.; Schmidt, J. M.; Chapuis, J.-C. Anti-Cancer Drug Design 1995, 10, 529-544.
15. 10. Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., Moos, W. H. J. Am. Chem. Soc. 1992, 114, 10646-10647.
16. 4 and water, respectively. The organic layer is evaporated in vacuo and the crude product is purified by HPLC.
17. 12. Frérot, E.; Coste, J.; Pantaloni, A.; Dufour, M.-N.; Jouin, P. Tetrahedron 1991, 47, 259-270.